Denali Therapeutics (DNLI) Other Operating Expenses (2024)
Historic Other Operating Expenses for Denali Therapeutics (DNLI) over the last 1 years, with Q1 2024 value amounting to $14.5 million.
- Denali Therapeutics' Other Operating Expenses changed N/A to $14.5 million in Q1 2024 from the same period last year, while for Dec 2024 it was $14.5 million, marking a year-over-year change of. This contributed to the annual value of $14.5 million for FY2024, which is N/A changed from last year.
- According to the latest figures from Q1 2024, Denali Therapeutics' Other Operating Expenses is $14.5 million.
- In the past 5 years, Denali Therapeutics' Other Operating Expenses ranged from a high of $14.5 million in Q1 2024 and a low of $14.5 million during Q1 2024